【网学提醒】：本文主要为网上学习者提供缬沙坦干预心肌梗死大鼠心室重构的实验研究*，希望对需要缬沙坦干预心肌梗死大鼠心室重构的实验研究*网友有所帮助，学习一下吧!
资料包括： 论文(5页3146字) 图纸
说明：
【摘要】 目的 探讨缬沙坦在心肌梗死后大鼠心室重构的作用机制。方法 结扎大鼠冠状动脉复制急性心肌梗死模型和充血性心力衰竭的大鼠动物模型；TUNEL法检测心肌细胞凋亡，用SP免疫组织化学方法染色检测心肌Bax蛋白表达。结果 心肌梗死大鼠凋亡心肌细胞数明显增多，其促凋亡基因Bax蛋白表达较对照组亦明显增强，尤其是急性期呈高表达（P＜0.01）；缬沙坦干预虽能抑制部分Bax蛋白的表达量，但仍明显强于对照组（P＜0.05）。结论 心肌细胞凋亡与其Bax表达过高有关；缬沙坦可能通过阻断血管紧张素Ⅱ而部分抑制心肌梗死时心肌细胞凋亡的发生，从而减轻或逆转心室重构。
【关键词】 心肌梗死,心室重构,凋亡,Bax蛋白,缬沙坦
Experimental study on myocardial remodeling interfered with valsartan in myocardial infarction of rats
【Abstract】 Objective To determine potential mechanisms of the valsartan to cardiomyocyte apoptosis and Bax protein expression in myocardial infarction of rats.Methods Animal model of acute myocardial infarction were established by ligating the left anterior descending coronary artery of rats，myocyte apoptosis were estimated by terminal deoxynucleotidyl transferase mediated dUTP nick end-labeling (TUNEL)，Bax protein expression of myocardium were semi-quantified by SP immunohistochemistry.Results Cell necrosis was the main manifestation in early stage，and then gradually increased the number of apoptotic cells and positively correlated to the expression of Bax protein，especially in acute stage (P＜0.01)；valsartan inhibited its expression to some extend (P＜0.05).Conclusion In infarcted myocardium，cardiomyocyte apoptosis is positively correlated to Bax protein expression，and they can be suppressed but not fully suppressed by the angiotensin II(Ang II) type 1 receptor blocker-valsartan.Valsartan can inhibit Ang Ⅱ and reduce the numbers of apoptotic cardiomyocyte.It is probably one of the mechanisms of the myocardial remodeling decreased by valsartan.
【Key words】 myocardial infarction；myocardial remodeling；apoptosis；Bax protein；valsartan
目录：
1 对象与研究
2 结果
3 讨论
参考文献：
1 Masoudi FA，Rathore SS，Wang Y，et al. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.Circulation，2004，110：724-731.
2 Dumont EAWJ，Hofstra L，Van Heerde WL. Cardiomyocyte death induced by myocardial ischemia and reperfusion：measurement with recoombinant human annexin-V in a mouse model. Circulation，2000，102(13)：1564-1568.
3 蔡文琴，王伯云.实用免疫细胞化学与核酸分子杂交技术.成 都：四川科学技术出版社，1994，177-188.
4 Keith AW，Nanette HB. Apoptosis inhibitors for heart disease. Circulation，2003，108：2954-2956.
5 Libera LD，Ravara B，Angelini A，et al. Beneficial effects on skeletal muscle of the angiotensin Ⅱ type 1 receptor blocker irbesartan in experimental heart failure. Circulation，2001，103：2195-2200.
6 Staessen JA，Thijs L，Birkenh ger WH. Value：analysis of results.Lancet，2004，364：931.
7 Verma S，Strauss M. Angiotensin receptor blocker and myocardial infarction. BMJ，2004，329：1248-1249.
8 Wong J，Patel RA，Kowey PR. The clinical use of angiotensin-converting enzyme inhibitors. Prog Cardiovasc Dis，2004，47：116-130.
9 Levy BI. Can angiotensin Ⅱ type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system. Circulation，2004，109：8-13.
10 Verdecchia P，Angeli F，Gattobigio R，et al. Do angiotensin Ⅱ receptor blockers increase the risk of myocardial infarction? European Heart Journal，2005，26：2381-2386.
